95% CI for HR | |||||||
---|---|---|---|---|---|---|---|
Variables | Regression coefficient | SE | Wald | p value | HR | Lower | Upper |
Late/early intervention with biological therapy | 2.652 | 0.922 | 8.27 | 0.004 | 8.323 | 2.256 | 30.696 |
RA duration | −0.05 | 0.08 | 0.391 | 0.532 | 0.951 | 0.813 | 1.113 |
Methotrexate (yes/no) | −1.086 | 0.446 | 5.917 | 0.015 | 0.338 | 0.141 | 0.81 |
Leflunomide (yes/no) | −2.158 | 1.228 | 3.083 | 0.079 | 0.116 | 0.01 | 1.283 |
Cyclosporine (yes/no) | −0.54 | 0.602 | 0.807 | 0.369 | 0.583 | 0.179 | 6.034 |
Sulfasalazine (yes/no) | 0.731 | 0.544 | 1.803 | 0.179 | 2.077 | 0.715 | 6.034 |
RA diagnosis age | −0.104 | 0.021 | 0.425 | 0.515 | 0.986 | 0.946 | 1.028 |
sex (female/male) | −0.11 | 0.557 | 0.039 | 0.843 | 0.896 | 0.301 | 2.668 |
Body mass index (kg/m2) | 0.017 | 0.059 | 0.086 | 0.769 | 1.018 | 0.906 | 1.143 |
Diabetes | −0.416 | 0.805 | 0.267 | 0.605 | 0.66 | 0.136 | 3.197 |